To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04006262
Title Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma. (NEONIPIGA)
Acronym NEONIPIGA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHRU Jean Minjoz Besançon France Details
Hôpital Henri Mondor Créteil France Details
Institut Hospitalier Franco-Britannique Levallois-Perret France Details
CHRU Lille Lille France Details
Centre Léon Bérard Lyon 69373 France Details
Hôpital Privé Jean Mermoz Lyon France Details
ICM Val d'Aurelle Montpellier France Details
CHU Nantes Nantes France Details
Hôpital Européen Geroges Pompidou Paris France Details
Hôpital Saint Antoine Paris France Details
Hôpital Saint Louis Paris France Details
Institut Mutualiste Montsouris Paris France Details
CHU Poitiers Poitiers France Details
CHU Pontchaillou Rennes Rennes 35033 France Details
CHU Toulouse Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field